GSK's expansion strategy through pandemic flu pays off

10/8/2009 | Wall Street Journal, The

GlaxoSmithKline's investment in products to combat H1N1 and bird flu infections has made it a global leader in the market of pandemic flu treatment. The strategy, which expanded GSK's portfolio from drugs and vaccines to diagnostic tools and medicated face masks, is expected to help the drugmaker sustain revenue as patents of its blockbuster drugs near expiration.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT